MeSH term
Frequency | Condition_Probility | English Abstract | 6 | 0.0 |
Humans | 157 | 0.0 |
Animals | 34 | 0.0 |
Adenocarcinoma/*metabolism | 3 | 3.0 |
Blotting, Western | 10 | 0.0 |
Female | 50 | 0.0 |
Immunoenzyme Techniques | 5 | 0.0 |
Mucins/*physiology | 2 | 15.0 |
Precipitin Tests | 6 | 0.0 |
Rats | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 100 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 64 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 19 | 0.0 |
Amino Acid Sequence | 20 | 0.0 |
Epithelium/metabolism | 12 | 3.0 |
Ligands | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Molecular Sequence Data | 33 | 0.0 |
Mucins/genetics/*metabolism | 11 | 28.0 |
Pregnancy | 2 | 0.0 |
Receptor, erbB-2/*metabolism | 2 | 1.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Disease Progression | 6 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Immunohistochemistry | 22 | 0.0 |
Mucins/*metabolism | 12 | 12.0 |
Tumor Markers, Biological/*metabolism | 4 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Mice | 12 | 0.0 |
Mucins/*genetics/*metabolism | 5 | 62.0 |
Organ Specificity | 3 | 0.0 |
Repetitive Sequences, Amino Acid | 3 | 2.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Trachea/metabolism | 2 | 11.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Rats, Inbred F344 | 2 | 0.0 |
Blotting, Northern | 18 | 0.0 |
In Situ Hybridization | 29 | 1.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 25 | 0.0 |
Sublingual Gland/*metabolism | 2 | 40.0 |
Submandibular Gland/*metabolism | 2 | 15.0 |
Gene Expression | 22 | 0.0 |
Mucins/biosynthesis/*genetics | 4 | 23.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
Tumor Markers, Biological/biosynthesis/genetics | 2 | 14.0 |
Conjunctiva/*metabolism | 3 | 21.0 |
Epithelial Cells/metabolism | 6 | 1.0 |
Goblet Cells/*metabolism | 2 | 33.0 |
Tears/metabolism | 3 | 42.0 |
Adult | 31 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Comparative Study | 10 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Male | 35 | 0.0 |
Middle Aged | 26 | 0.0 |
Mucins/genetics/immunology/*metabolism | 3 | 60.0 |
RNA/isolation & purification | 2 | 3.0 |
RNA, Messenger/metabolism | 17 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Mucins/*genetics | 38 | 34.0 |
Pancreatic Neoplasms/*genetics | 4 | 4.0 |
Prognosis | 5 | 0.0 |
Tumor Markers, Biological/metabolism | 3 | 0.0 |
Cell Line, Tumor | 7 | 0.0 |
Immunotherapy | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
RNA, Messenger/analysis | 16 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Epithelium/physiology | 3 | 3.0 |
Molecular Weight | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Viscosity | 2 | 6.0 |
Aged | 26 | 0.0 |
Base Sequence | 16 | 0.0 |
Gallbladder/*metabolism | 3 | 23.0 |
Carbohydrates/chemistry | 2 | 20.0 |
Pancreatic Neoplasms/*metabolism | 2 | 2.0 |
RNA, Messenger/biosynthesis | 6 | 0.0 |
Aged, 80 and over | 8 | 0.0 |
Chronic Disease | 6 | 0.0 |
*Gene Expression Regulation, Neoplastic | 8 | 0.0 |
Mucins/analysis/*genetics | 3 | 20.0 |
Reference Values | 6 | 0.0 |
Tumor Markers, Biological/*analysis | 7 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Retrospective Studies | 3 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Glycosylation | 9 | 0.0 |
Lung Neoplasms/*genetics/metabolism | 2 | 5.0 |
Mucins/*genetics/metabolism | 11 | 39.0 |
Protein Isoforms/genetics | 3 | 1.0 |
Progesterone/pharmacology | 2 | 1.0 |
Respiratory Mucosa/*metabolism | 2 | 14.0 |
Gastric Mucin/genetics/metabolism | 2 | 100.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Stomach Neoplasms/*genetics | 2 | 1.0 |
Adolescent | 4 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Cell Line | 11 | 0.0 |
Breast/metabolism | 2 | 2.0 |
CA-15-3 Antigen/genetics | 4 | 28.0 |
*Gene Expression | 10 | 0.0 |
Salivary Proteins/genetics | 3 | 60.0 |
CA-15-3 Antigen/metabolism | 6 | 18.0 |
Carbohydrate Sequence | 4 | 1.0 |
Transcription, Genetic | 5 | 0.0 |
Immunization | 2 | 0.0 |
Mucins/*immunology | 3 | 13.0 |
CA-15-3 Antigen/genetics/metabolism | 3 | 50.0 |
Up-Regulation | 6 | 0.0 |
Binding Sites | 2 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Colon/metabolism | 3 | 2.0 |
Endopeptidases/metabolism | 2 | 1.0 |
Pancreas/metabolism | 3 | 3.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Gastric Mucin/*metabolism | 2 | 25.0 |
Gestational Age | 5 | 0.0 |
Histocytochemistry | 4 | 0.0 |
Keratin/analysis | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Receptors, Retinoic Acid/metabolism | 2 | 2.0 |
Tretinoin/pharmacology | 3 | 0.0 |
Carcinoma, Squamous Cell/*metabolism/pathology | 2 | 2.0 |
Neoplasm Staging | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mucins/*analysis | 3 | 7.0 |
Neoplasm Recurrence, Local | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Mucins/*biosynthesis/genetics | 4 | 18.0 |
Predictive Value of Tests | 2 | 0.0 |
Adenocarcinoma/*genetics/metabolism | 3 | 7.0 |
Pancreatic Neoplasms/*genetics/metabolism | 2 | 11.0 |
Polymorphism, Genetic | 3 | 0.0 |
RNA, Neoplasm/analysis | 3 | 1.0 |
Immunohistochemistry/methods | 4 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Adenocarcinoma/metabolism | 2 | 2.0 |
Metaplasia | 2 | 2.0 |
Stomach/embryology/*metabolism/pathology | 2 | 100.0 |
Stomach Neoplasms/*metabolism | 2 | 4.0 |
Cell Differentiation/genetics | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Alleles | 2 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Phenotype | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Epitopes/metabolism | 2 | 3.0 |
Cells, Cultured | 6 | 0.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Conjunctiva/*chemistry | 2 | 40.0 |
Epithelium/chemistry | 3 | 2.0 |
Hyperplasia | 3 | 0.0 |
Respiratory System/*metabolism | 4 | 28.0 |
Receptor, erbB-2/genetics/*metabolism | 2 | 6.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Carcinoma/*metabolism | 2 | 2.0 |
Mucins/*biosynthesis | 5 | 13.0 |
Conjunctiva/*physiology | 2 | 100.0 |
Epithelium, Corneal/*physiology | 2 | 50.0 |
Gene Expression/drug effects | 2 | 0.0 |
Intestinal Mucosa/metabolism | 2 | 1.0 |
Microscopy, Electron | 4 | 0.0 |
Exons | 3 | 0.0 |
Introns | 2 | 0.0 |
Epithelial Cells/cytology/physiology | 2 | 6.0 |
Neoplasm Metastasis | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Lung Neoplasms/*metabolism | 2 | 2.0 |
Mucins/genetics/*secretion | 2 | 66.0 |
*Gene Expression Regulation | 6 | 0.0 |
DNA, Complementary | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
RNA, Messenger/*analysis | 4 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Survival Analysis | 3 | 0.0 |
Epithelium/immunology | 2 | 1.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Tears/*physiology | 2 | 66.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Mucins/genetics | 3 | 15.0 |
Minisatellite Repeats | 2 | 1.0 |
Submandibular Gland/metabolism | 2 | 14.0 |
Luciferases/genetics | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
HT29 Cells | 2 | 1.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Adenocarcinoma/genetics/metabolism | 2 | 10.0 |
Pancreatitis/genetics/metabolism | 2 | 66.0 |
Protein Binding | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Microscopy, Phase-Contrast | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 3 | 0.0 |
Cell Division | 2 | 0.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Transplantation, Heterologous | 3 | 0.0 |
*Bile Ducts, Intrahepatic | 2 | 6.0 |
Respiratory System/metabolism | 2 | 20.0 |
Conjunctiva/*cytology | 3 | 42.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Coculture Techniques | 2 | 0.0 |
Mice, SCID | 2 | 0.0 |
Pancreatic Neoplasms/genetics/*metabolism/pathology | 2 | 16.0 |
